Management of Rhegmatogenous Retinal Detachment during COVID-19 Pandemic

Adel G. AlAkeely1, *, Abeer Habeeb2
1 Retina Division, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia
2 College of Medicine, Taibah University, Medina, Saudi Arabia

Article Metrics

CrossRef Citations:
Total Statistics:

Full-Text HTML Views: 80
Abstract HTML Views: 55
PDF Downloads: 49
Total Views/Downloads: 184
Unique Statistics:

Full-Text HTML Views: 64
Abstract HTML Views: 39
PDF Downloads: 44
Total Views/Downloads: 147

Creative Commons License
© 2021 AlAkeely and Habeeb.

open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: ( This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

* Address correspondence to this author at the Retina Division, King Khaled Eye Specialist Hospital, Umm al Hamam Al Gharbi, Al Urubah Branch Road, Riyadh, Saudi Arabia; Email:


Patients with primary Rhuegmatougenous Retinal detachment during COVID-19 pandemic were more likely to present late, have macula involving disease secondary and to show poor visual outcomes. Pneumatic Retinopexy (PR) is a procedure that eliminates the need for admission and limits the duration of contact with patients. Hence, more feasible during periods of shortage in hospital beds and medical personnel in the pandemic. In our experience, we successfully performed pneumatic retinopexy on two confirmed COVID-19 cases with favourable visual outcomes. We would recommend retina surgeons be familiar with such procedure as it may be a good alternative to conventional treatment while minimizing the risk of transmitting COVID-19.

Keywords: Rhegmatogenous retinal detachment, Pneumatic retinopexy, COVID-19, Horseshoe Tear, Personal protective equipment, Pars plana vitrectomy.